Search
170 studies match these filters. Showing 1–25 of 170 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT07213778 | REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 57 sites in total | Recruiting | Phase 3 | 2,000target | 57 / 5 | 2025 | Nov 19, 2026 | |
| NCT04613596 | Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS and who are candidates for first-line treatment. The Phase 3 portion of the study com… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 776 sites in total · contact listed | Recruiting | Phase 2 / Phase 3 | 626target | 776 / 47 | 2020 | Nov 19, 2026 | |
| NCT06956014 | Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were un… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 43 sites in total · contact listed | Recruiting | Phase 3 | 810target | 43 / 1 | 2026 | Nov 19, 2026 | |
| NCT07466316 | A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS) This phase III trial compares higher dose chemotherapy, with vincristine, dactinomycin and cyclophosphamide, over a shorter amount of time to lower dose chemotherapy plus maintenance, with vincristine, dactinomycin, cyclophosphamide, irinotecan and vinorelbine, over a longer amount of time, along wi… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 138 sites in total · contact listed | Recruiting | Phase 3 | 342target | 138 / 2 | 2026 | Nov 19, 2026 | |
| NCT02402244 | Project: Every Child for Younger Patients With Cancer This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 279 sites in total · contact listed | Recruiting | 75,000target | 279 / 6 | 2015 | Nov 19, 2026 | ||
| NCT06581328 | A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 months… ✓ Contact✗ Claimed Nearest site: Hutchinson, Kansas, United States — 36 km away · 101 sites in total · contact listed | Recruiting | Phase 4 | 200target | 101 / 1 | 2025 | Nov 18, 2026 | |
| NCT07685808 | Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes This study will test an experimental drug called olatorepatide ("study drug") to determine how safe and effective this drug is compared to placebo and how easily the body can accept this drug at different doses and dosing schedules without causing side effects, as well as how the drug is processed i… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 22 sites in total | Recruiting | Phase 2 | 360target | 22 / 1 | 2026 | Nov 18, 2026 | |
| NCT06393374 | Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and di… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 317 sites in total | Recruiting | Phase 3 | 1,530target | 317 / 31 | 2024 | Nov 18, 2026 | |
| NCT07629440 | A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can cause pneumonia (lung infections), meningitis (brain infections), and otitis media (ear infections) in infants when compared to the pneumoco… ✓ Contact✗ Claimed Nearest site: Derby, Kansas, United States — 54 km away · 134 sites in total | Recruiting | Phase 3 | 3,230target | 134 / 3 | 2026 | Nov 18, 2026 | |
| NCT07636590 | Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 21 sites in total · contact listed | Recruiting | 500target | 21 / 1 | 2026 | Nov 18, 2026 | ||
| NCT07780669 | A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1) The study primarily aims to demonstrate the superiority of GSK5784283 as an add-on therapy compared to placebo in reducing the annualized rate of moderate and severe chronic obstructive pulmonary disease (COPD) exacerbations. ✓ Contact✗ Claimed Nearest site: Derby, Kansas, United States — 54 km away · 11 sites in total · contact listed | Recruiting | Phase 3 | 624target | 11 / 2 | 2026 | Nov 17, 2026 | |
| NCT07159763 | A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06) Approximately one billion cases of seasonal influenza occur annually. Of these, 3 to 5 million illnesses are severe and responsible for up to 650,000 deaths per year (WHO 2025). Yearly administration of an influenza vaccine for the prevention of influenza is currently recommended. However, the real-… ✓ Contact✗ Claimed Nearest site: Hutchinson, Kansas, United States — 36 km away · 211 sites in total · contact listed | Recruiting | Phase 3 | 10,000target | 211 / 6 | 2025 | Nov 17, 2026 | |
| NCT07915791 | A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) This study is for adult participants with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) who continue to experience exacerbations despite standard of care triple therapy treatment. It will assess the effectiveness and safety of two investigational drugs, GSK3862995B and GSK5784283,… ✓ Contact✗ Claimed Nearest site: Derby, Kansas, United States — 54 km away · 10 sites in total · contact listed | Recruiting | Phase 2 | 279target | 10 / 2 | 2026 | Nov 17, 2026 | |
| NCT07746531 | Robotic Minimally Invasive Benign Hysterectomy Post-Market Clinical Study With the DEXTER Robotic System The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device performs as intended (accurate, precise control of surgical instruments) in patients undergoing robotic-assisted and laparoscopic hysterectomy for benign disease. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 2 sites in total · contact listed | Recruiting | 112target | 2 / 1 | 2026 | Nov 17, 2026 | ||
| NCT04566328 | Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell g… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 647 sites in total | Recruiting | Phase 3 | 1,450target | 647 / 2 | 2021 | Nov 16, 2026 | |
| NCT07136012 | OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization in participants at risk for a first major cardiovascular event with elevated lipoprotein(a) (Lp\[a\]). ✓ Contact✗ Claimed Nearest site: Hutchinson, Kansas, United States — 36 km away · 261 sites in total | Recruiting | Phase 3 | 11,000target | 261 / 4 | 2025 | Nov 16, 2026 | |
| NCT07543120 | An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. The purpose of this extension study is to collect additional safety and efficacy on QCZ484 for hypertensive patients who successfully completed the parent study, CQCZ484A12201 or additional QCZ484 studies as specified in the respective parent study protocols. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 46 sites in total · contact listed | Recruiting | Phase 2 | 323target | 46 / 3 | 2026 | Nov 16, 2026 | |
| NCT07220083 | A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS) PODOMOUNT-pFSGS This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 helps people with FSGS. Participants are put into 2 groups randomly, which means by ch… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 309 sites in total · contact listed | Recruiting | Phase 3 | 286target | 309 / 37 | 2026 | Nov 13, 2026 | |
| NCT07190300 | TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) The purpose of this study is to evaluate the safety, tolerability, and efficacy of two different treatment combinations of tulmimetostat in participants with de novo or recurrent metastatic hormone-sensitive prostate cancer (mHSPC). Phase I aims to determine the recommended dose(s) for expansion (RD… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 31 sites in total · contact listed | Recruiting | Phase 1 / Phase 2 | 181target | 31 / 14 | 2026 | Nov 13, 2026 | |
| NCT07798726 | TransCatheter Replacement Of the Mitral Valve With the Novel Cephea Mitral Valve System The objective of this clinical trial is to evaluate the safety and effectiveness of the Cephea Mitral Valve System in subjects with symptomatic mitral valve disease (MVD) or are deemed unsuitable for surgery and transcatheter repair. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · contact listed | Recruiting | Not applicable | 565target | 1 / 1 | 2026 | Nov 13, 2026 | |
| NCT06819878 | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy with Afimkibart (also known as RO7790121) in participants with moderately to severely active Crohn's disease (CD). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 375 sites in total | Recruiting | Phase 3 | 600target | 375 / 38 | 2025 | Nov 13, 2026 | |
| NCT06935370 | A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the study if they have been diagnosed with chronic HF at least 3 months before they start on the study. The purpose of this study is to find out… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 596 sites in total · contact listed | Recruiting | Phase 3 | 4,200target | 596 / 29 | 2025 | Nov 12, 2026 | |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglifl… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 1,142 sites in total · contact listed | Recruiting | Phase 3 | 11,800target | 1,142 / 51 | 2025 | Nov 12, 2026 | |
| NCT06424288 | A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in combination with empag… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 672 sites in total · contact listed | Recruiting | Phase 3 | 6,712target | 672 / 30 | 2024 | Nov 12, 2026 | |
| NCT07321899 | Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 20 sites in total · contact listed | Recruiting | Not applicable | 1,186target | 20 / 1 | 2026 | Nov 12, 2026 |